chrisvoncsefalvay/vaers-outcomes huggingface dataset:
VAERS completed because of being Tested positive for COVID-19 infection 14 or more days after being fully vaccinated. 1st dose 12/27/21 Lot#039K20-2A 2nd dose 01/24/21,lot#013L20A Diagnosed covid positive:08/10/21 Symptom onset:08/05/21 Exposure: Symptoms:Runny nose.
This is a 79-year-old male who presented from home with weakness and cough; found to be COVID-19 positive. He was placed on remdesivir and Decadron; he fared well during this hospital stay. Will be discharged on Decadron. He will wean off O2 while at SNF; today only requiring 1 L. Was placed on small dose Lantus while on steroid.   Comments/Problems to be Addressed after Discharge Wean off O2 at SNF
I developed areas of  hives/rash over several parts of my body.; I developed areas of  hives/rash over several parts of my body.; Urticarial Hypersensitivity Reaction; This is a spontaneous report from a contactable nurse (patient) and physician. A 64-year-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EK9231), via an unspecified route of administration, administered in arm left on 09Jan2021 at 19:00 (07:00 PM) as, dose 1, single for COVID-19 immunization. Second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot Number: EL9262), via an unspecified route of administration, administered in arm left on 30Jan2021 at 04:00 PM as dose 2, single for COVID-19 immunization. Medical history was reported as none. Patient had no known allergies. The patients took dietary supplement within in two weeks of vaccination. The patient did not receive any other vaccine in four weeks. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 16Jan2021, the patient experienced I developed areas of hives/rash over several parts of my body, urticarial hypersensitivity reaction. Adverse events resulted in doctor or other healthcare professional office/clinic visit. Adverse event: I developed areas of hives/rash over several parts of my body. This began after the first vaccine (not immediately, days later) and became severe after the second vaccine dose. I saw my dermatologist DR. I also saw an allergist and had extensive allergy testing done. I eventually had a biopsy of the rash done. It showed Urticarial Hypersensitivity Reaction. It was reviewed by Dr. The patient underwent lab tests and procedures which included allergy testing was unknown; biopsy: urticarial hypersensitivity reaction. Patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. The patient received treatment for the events. The outcome of all the events was not recovered.  No follow-up attempts are possible. No further information is expected.
Flu vaccine gotten 10/05/05 pt c/o arm hurting off and on since injection. No visible problem at all, just hurts. She first called health dept. 11/21/05 to report continues to hurt off and on. Aleve and Ibuprofen not helped.
very sore arm around injection site, very achy, fatigued, felt terrible over all, cold not work,  the next day, about 50 % better, the third day was back to normal.
5 years ago received ZOSTAVAX with no problem. At the doctor office, patient was not asked to sit down for 15 minutes. About 3 hours later started getting pain/soreness on arm--did not expect to get it that fast. Also got a headache. The shot itself was painful. Next day, more pain/soreness in arm than the day before, also swelling and redness. Equilibrium problems started so had problem walking and/or driving. By mid-day got dry heaves and dizzinessit got so bad that could not drive car. Patient could not eat much for 2 days and just drank fluids. On the 2nd day called pharmacist. Patient put Benadryl gel on arm and took liquid Benadryl but did not help. On the 4th day, arm blew up like balloon (2 times, balloon (2 times the size), red and hot. Patient did not have fever, but was very sore and then stayed sick with dizziness for 5 days straight. Eventually arm peeled like had severe sunburn. For 2 days after, had baby rash going down and across the arm. Patient did not contact doctor at any point. Today, patient finally feeling better. The arm still hurts, swelling has gone down as well as dizziness.
1. I lost hearing in my Right Ear next day 2. My head was fill with fluid and pocket air 3. My ears is not stop ringing  4. My balance is bad, cant stand up 5. fatigue  6. Dizziness 7.Cant walk. 8. equilibrium is bad- seeking therapy
Patient developed left-sided neck pain approximately 48 hours after receiving varicella vaccination.  The neck pain was related to any head movement in any direction.  Physical examination yielded tender unilateral left-sided cervical and supraclavicular lymphadenopathy.  No fever, chills, or upper repiratory symptoms.  No submandibular, pre-auricular, occipital, axillary, or inguinal adenopathy noted.  No hepatosplenomegaly noted on abdominal examimation.
At approx 7:25 pm on 6/26/12 patient's arm and right side seemed to start cramping and patient would bring his head to shoulder to try & stop the cramping - Rt head tilt with (R) shoulder elevation & twisting, clenching of (R) hand last 5-10 seconds & persistent for 1 1/2 hrs.
On 8/1/01, at the time of the injection, the pt became weak and "slumped-like in chair". She did not lose consciousness. Pt was very nervous about receiving the injection. A few days later, it was reported that the pt began having "spells" and has lost consciousness at least 2 times for "a few seconds" (less than 5 sec). Since then pt has experienced "spells" of nausea, sweating, malaise, chills, weakness, flushing, anorexia, insomnia, irritable and easily agitated. She is seeing PP and referred to cardiologist. Symptoms continue to occur rather frequently.
This spontaneous report was received from a physician, via company representative, and refers to a patient of unknown age and gender. The patient's pertinent medical history, concurrent conditions, concomitant therapies, drug reactions or allergies were not reported. On 06-JUN-2016, the patient was vaccinated with an improperly stored dose of PNEUMOVAX 23 10 PK, lot # L002310, expiration date 08-JUL-2016, at a dose of 0.5 ml (route and anatomical location of administration were unspecified). The vaccine underwent a total temperature excursion, of 48 hours. The highest recorded temperature was 47 Fahrenheit degrees (8.333333333 Celsius). The vaccine status was reported as "in excursion". The vaccine storage criteria and the vaccine excursion were reported as "Refrigerator(R)". No adverse effects were reported. No Product Quality Complaint (PQC) was involved. This is one of several reports received from the same reporter. Additional information has been requested.
I had normal covid vaccine sideffects throughout the night. Then around 8am my heart rate shot up in the 110 -120 bpm range. This remained at a high rate for several hours. In addition to this i was having severe heart palpitations. I ended up needing to go to urgent care where they gave me an iv of saline and beta blockers to slow my heart.
Initial information received on 24-Jul-2018 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 6 months old female patient who received 0.5 ml single dose of vaccine PENTACEL via intramuscular route in left thigh on 23-Jul-2018. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included HEPATITIS B VACCINE; PREVNAR 13; and ROTAVIRUS VACCINE. It was a case of actual medication error due to expired vaccine used. It was reported that patient was brought in for her PENTACEL vaccine and after injection it was noticed that the diluent was expired (expiry date: 01Jun2018). It was unknown if patient had any adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. Documents held by sender: None.
7 people had died from Pfizer; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP), Program ID: (RA).  An elderly (reported as "50-99" and "Age Group: Elderly (greater than equal to 65 years)") male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunization. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DEATH (death), outcome "fatal", described as "7 people had died from Pfizer". The date and cause of death for the patient were unknown. It was not reported if an autopsy was performed.  Clinical course: Age + years/months/days: 50-99. Age Group: Elderly (greater than equal to 65 years). Moderna has proven to be effective against COVID-19; Pfizer is not that effective when the reporter first heard about it. 7 people had died from Pfizer; So that made a change in mind about taking Moderna. Plus, the Primary Care doctor suggested Moderna based of these stories that the reporter heard. The reporter considers the event as caused by the suspect product.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-PV202300139954 Same reporter/event/drug, different patient;; Reported Cause(s) of Death: 7 people had died from Pfizer
Injection site (Left tricep area) swelling, warm, itchy, rash extends 5 inches below right elbow. Sx started within one hour, and got worse. Patient had similar reaction with previous injections which resovled in 2 weeks. Patient will be initiating treatment today.
instead of giving the booster dose, additional dose was given. however, no adverse reaction reported and patient states it is fine with him.
Initial information received on 08-Feb-2019 regarding an unsolicited valid non-serious case received from a other health professional. This case involves 08-year-old male patient was vaccinated with second dose of IPOL (lot: P1A242M, expiry date: 26-Apr-2020) via intramuscular route in the left deltoid, which had a temp excursion on 04-Feb-2019. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included HEPATITIS B VACCINE; ADACEL; MMR and VARICELLA ZOSTER VACCINE Immunisation. It is an actual medication error case due to incorrect product storage. It was reported that the vaccine stored at temperature outside the recommended range. It was unknown if the patient had any adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive and Module VI of the Good Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. List of document held by sender: none.
Burning itchy eyes.  Feeling like he has something stuck in the back of his eyes.  Client stated he had similar reaction after receiving first dose.
Patient experienced facial rash with dose 1 that was relieved with Benadryl 50mg PO. Patient experienced spreading body rash with difficulty breathing experienced as persistent cough with dose 2.  Symptoms were not relieved with Benadryl 50mg PO and continued to worsen.  Patient was administered 0.3mg epinephrine IM (as EpiPen), 911 was alerted, and an ambulance took patient to hospital.
First seizure occurred 3-27, called paramedics who took him to the ER. Seizure way not focal, clonic movements lasted approximately 5 mins. Fever 103.8 ER gave TYLENOL and d/c'd patient. 3-28 - twitching - non-focal ? approximately 10 mins. Went to ER temp 102.8 mom had been alternating MOTRIN and TYLENOL.
ACUTE NON ST ELEVATION MI 4/19/2023 ACUTE NON ST ELEVATION MI ACUTE NON ST ELEVATION MI 4/19/2023 ACUTE NON ST ELEVATION MI
Pain at injection site that is not constant, pain can be described as sharp or pinching. The pain is still occurring approximately 9 weeks after the most recent dose.
Breathing difficult; Sickness; Chills; Nauseous; Vaccination site pain; Sleepy; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Breathing difficult ), SOMNOLENCE (Sleepy), ILLNESS (Sickness), VACCINATION SITE PAIN (Vaccination site pain) and CHILLS (Chills) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced SOMNOLENCE (Sleepy) and VACCINATION SITE PAIN (Vaccination site pain). On 05-Mar-2021, the patient experienced DYSPNOEA (Breathing difficult ), ILLNESS (Sickness), CHILLS (Chills) and NAUSEA (Nauseous). At the time of the report, DYSPNOEA (Breathing difficult ), SOMNOLENCE (Sleepy), ILLNESS (Sickness), VACCINATION SITE PAIN (Vaccination site pain), CHILLS (Chills) and NAUSEA (Nauseous) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Relevant concomitant medications were not reported.  Treatment information was not provided. Patient developed soreness at injection site , right after the vaccine shot at the injection site. and after 5 hours after the shot felt very sleepy and slept for 38 hours. Patient also developed very bad chills, nauseous, felt very sick , and little bit breathing difficulties 20 hours after the vaccine shot.
I was diagnosed with Covid 12/02/2022 I started sneezing 12/01/2022, coughing blood up. 12/02/2022 went to urgent care clinic fever of 101, tested for Covid and resulted in positive results. Loss of appetite; fatigue and coughing blood, by Monday blood cleared from mucus. Chills and body aches treated with extra strength TYLENOL.
The day after shot my new replacement prosthetic knee (surgery August 30, 2021) began to swell a lot, have heat and pain. A week later it was the same way. I saw the doctor yesterday and they doubled celecoxib for swelling and said it was soft tissue swelling. I was doing great in physical therapy and had no swelling the morning before the vaccination.
patient started having chills and palpitation 10-15 minutes post vaccination, patient was given some water and her legs were elevated and she strated feeling better after 20-25 minutes. She waited in pharmacy area for 35 minutes and left once she felt normal/comfortable
15-20 minutes after injection felt sore in neck and lower back; few hours later body aches, lightheaded and fatigue.  Symptoms remain the same today 12/ 24/2020
Given a first dose of the Moderna vaccine of 1ml instead of .5 ml; A spontaneous report was received from a pharmacist concerning a patient who received Moderna's COVID-19 vaccine (mRNA-1273) and was given a first dose of the Moderna vaccine of 1 mL instead of 0.5 mL.   The patient's medical history was not provided. No relevant concomitant medications were reported.   The patient received their first of two planned doses of mRNA-1273 on 29 Dec 2020 intramuscularly for prophylaxis of COVID-19 infection. During the administration, the pharmacist stated that the patient was given a first dose of the vaccine of 1.0 ml instead of 0.5 ml. Treatment information was not provided.   Action taken with mRNA-1273 in response to the event was not reported.  The outcome of event was not reported.; Reporter's Comments: This case concerns a male patient who received their first of two planned doses of mRNA-1273 (Lot 011L20A), reporting Incorrect dosage administered without any associated adverse events.
Body Ache; Congestion; tested positive for covid; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (tested positive for covid), MYALGIA (Body Ache) and NASAL CONGESTION (Congestion) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced COVID-19 (tested positive for covid). On an unknown date, the patient experienced MYALGIA (Body Ache) and NASAL CONGESTION (Congestion). At the time of the report, COVID-19 (tested positive for covid), MYALGIA (Body Ache) and NASAL CONGESTION (Congestion) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant information  provided. No Treatment information  provided
Dizziness and headache occurred. Chronic migraines developed -- never had headaches before thought to have caused trauma to both inner ear canals. Ongoing migraines being treated by neurologist resulting in depression and anxiety.
Information has been received from a physician assistant concerning a female (age not reported) who on 25-MAR-2008 was vaccinated with the third dose of GARDASIL (lot # not reported).  On 25-MAR-2008 while in the office, the patient fainted.  On 25-MAR-2008, the patient recovered.  There was no product quality control involved.  Additional information is not expected.
HEART RACING; DIFFICULTY BREATHING; TACHYPNEA; FEELING HOT; MUSCLE PAIN IN LEFT LEG; TIRED; HEADACHE; This spontaneous report received from a patient concerned a 33 year old male. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included no known drug allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 041A21A, expiry: UNKNOWN) dose was not reported, administered on 05-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 05-APR-2021, the subject experienced feeling hot. On 05-APR-2021, the subject experienced muscle pain in left leg. On 05-APR-2021, the subject experienced tired. On 05-APR-2021, the subject experienced headache. On 07-APR-2021, the subject experienced tachypnea. On 08-APR-2021, the subject experienced difficulty breathing. On 08-APR-2021, the subject experienced heart racing. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from difficulty breathing, heart racing, and tired on 09-APR-2021, tachypnea, and headache on 08-APR-2021, and feeling hot, and muscle pain in left leg on 06-APR-2021. This report was non-serious.
I developed a 2inch reddened circle on the arm where I received the vaccine 1 week later.  Over the course of 2 days it became raised popular and itchy.  Then I began having the same type of rash mainly on my trunk and hips a few scattered on legs and arms  Very itchy
Tinnitus; chest palpitations; shoulder pain; diarrhea; total back pain; muscular pain; exhaustion; foggy brain; smell of smoke; This is a spontaneous report from a contactable consumer (patient herself). A 64-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Lot Number: R8732), via an unspecified route of administration, administered in Arm Right on 01Apr2021 12:00 (age ta vaccination: 64 years) as DOSE 2, SINGLE; dose 1 via an unspecified route of administration, administered in Arm Right on 11Mar2021 12:00 (Batch/Lot Number: EN6208) as DOSE 1, SINGLE for covid-19 immunisation. The patient's medical history included bees allergy. The patient's concomitant medications were not reported. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 08May2021 01:00, the patient experienced tinnitus, chest palpitations, shoulder pain, diarrhea, total back pain, muscular pain, exhaustion, foggy brain and smell of smoke. The patient was treated with steroid for the adverse events. The adverse events resulted in physician's office visit. The patient was diagnosed with COVID-19 prior to vaccination but was not tested since vaccination. The outcome of all the events was not recovered. The device date was 24Aug2021.  Follow-up attempts are completed. No further information is expected.
My son was COVID-19 positive, on the 02/05/2023. I was feeling feverish and crummy. I had cold flu like symptoms. I did test on that day, but I was negative. The next day I was positive from a home. I contacted telehealth and was given PAXLOVID. I felt worse before I started to feel better. I did come down with a cold that was pretty bad on mid-March. I was feeling fatigue, runny nose and I lost my voice. It was a long two weeks. The laryngitis lasted at least week.
Patient had extreme pain in shoulder joint immediately following vaccination x3 days. Patient stated pain was 8-9 and pain is burning. Went to walk-in clinic and received ibuprofen and injectable steroid.
injection site was sore for over a month, and othersoft tissue / musculoskeletal issues flared up, causing problems with dressing and washing hair that eventually subsided. Unclear whether there may have been an interaction with medications (Dyazide side effects), hyperthyroid (later discovered was on too high a dose of thyroid meds) and/or a flare of immune overreaction. No adverse reaction to second COVID shot
Sore left shoulder for 10 days, very large hard feverish lump at injection site. Treatment was TYLENOL to ease pain.
pt brought to ED with generalized weakness, cough, congestion and diarrhea x 10-14 days; positive for COVID; dx with COVID pneumonia after chest x-ray; admitted to hosp; treated with dexamethasone, O2, inhales, DVT prophylaxis; pt placed on high flow O2 then changed to BiPAP with improvement; pt's condition deteriorated and required intubation; DNR; condition worsened and pt died in the hosp
Shingles; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a currently 65 years old female patient. Information regarding medical history, concurrent conditions, or concomitant medications was not provided.  On or about 01-MAY-2017, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (lot#, expiration date, dose, dose# and route not specified), for the long-term prevention of shingles and zoster-related conditions.  On an unknown date, the patient experienced shingles. On an unspecified date, the patient was treated by a healthcare provider for shingles. The outcome of shingles was unknown. The reporter considered shingles to be related to Zoster Vaccine Live (ZOSTAVAX).  Additional information has been requested.
On 8/25/21 started having migraines. On 8/26/21 had swollen right sided clavicle lymph node, tingling down right arm, pressure on chest, continued migraines.
Began to get a fever at 6:00pm.  Fainted at 8:00pm.  Ambulance ride to hospital.  Couldn't open my eyes, had a fever of 103-105, heart rate would rise when I went from a seated position to standing.